Bone Therapeutics S.A. Caladrius Biosciences Inc. Iovance Biotherapeutics Inc. Lonza Group AG
Merck KGaA
Novartis AG
Regen BioPharma Inc. Regeneus Ltd. The Bristol-Myers Squibb Company (BMS)
Published | Pages | Publisher | Report code |
---|---|---|---|
Aug 2022 | 80 | GEN Consulting | ASDR-607593 |
Bone Therapeutics S.A. Caladrius Biosciences Inc. Iovance Biotherapeutics Inc. Lonza Group AG
Merck KGaA
Novartis AG
Regen BioPharma Inc. Regeneus Ltd. The Bristol-Myers Squibb Company (BMS)